The influence of the glucagon‐like peptide‐1 receptor agonist, liraglutide, on dietary patterns and nutrient intakes in patients with obesity and prediabetes: A secondary analysis of a randomized controlled trial
Overall diet quality was poor across all groups. However, the caloric restriction group significantly reduced its added sugar intake, highlighting a potential benefit nutrition counselling may have for AOM users. Future research is needed to examine the long-term impact of AOM use on dietary intake, with and without nutrition guidance, to better inform clinical recommendations.
Authors
- Heidi J. Silver (ORCID: https://orcid.org/0000-0003-2237-4903)
- Susan M. Schembre (ORCID: https://orcid.org/0000-0002-9945-7136)
- Kelli M Richardson (ORCID: https://orcid.org/0000-0001-7418-252X)
- Annaliese Widmer (ORCID: https://orcid.org/0000-0002-4647-3589)
- Michelle R Jospe (ORCID: https://orcid.org/0000-0003-0393-5517)
Institutions
- Georgetown University (US)
- Georgetown University Medical Center (US)
- VA Tennessee Valley Healthcare System (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1111/dom.16395
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- American Heart Association
- National Center for Advancing Translational Sciences